Skip to content
  • About Impel
    • Impel History
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Collaborations
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Join Impel
  • Investors
  • Contact
  • About Impel
    • Impel History
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Collaborations
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Join Impel
  • Investors
  • Contact

Leadership

  • Impel History
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Collaborations

Leadership

Adrian Adams Headshot
Adrian Adams

Chairman & CEO

John-Hoekman
John Hoekman

Chief Technology & Development Officer

Rajiv Amin
Rajiv Amin

Vice President, Corporate Controller
& Interim Chief Financial Officer

Stephen-Shrewsberry
Stephen Shrewsbury

Chief Medical Officer

Leonard S. Paolillo
Leonard S. Paolillo

Chief Commercial Officer

Lynn-Gold
Lynn Gold

Senior VP of Regulatory

Scott-Youmans
Scott Youmans

Senior VP of Technical Operations

Mike-Malafronte
Michael Malafronte

VP of Quality Assurance

Jen-Berman
Jen Berman

VP of Marketing

Sheena K. Aurora, M.D.
Sheena K. Aurora, M.D.

VP of Medical Affairs

Rigo Canal
Rigo Canal

VP of Commercial Operations & Analytics

Gerald F. Penn
Gerald F. Penn

VP of Market Access & Trade

Patty Billingsley
Patty Billingsley

VP of Sales

Sarah Wille
Sarah Wille

VP of Human Resources

Joe Smith
Joe Smith

VP of Business Development

CONNECT WITH US
Icon Twitter link to Twitter Icon LinkedIn link to linkedIn
Impel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high unmet medical needs.

IMPEL, POD, Trudhesa, Trudhesa DIRECT, and the Impel and Trudhesa Logos are trademarks of Impel Pharmaceuticals, Inc. Other trademarks are the property of the respective owner(s).

Impel Pharmaceuticals

201 Elliott Avenue West, Suite 260
Seattle, WA 98119

Phone: 206.568.1466

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure

© 2023 Impel Pharmaceuticals Inc. All Rights Reserved.

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure